Molecular Diagnostics
TB Sequencing Could Replace Drug Susceptibility Testing
Tuberculosis (TB) is the most deadly infectious disease worldwide, causing 1.6 million deaths in 2017. Drug resistance is a particularly challenging and growing problem: as in 2017, it was estimated that 558,000 new cases of TB were resistant to rifampicin, the most effective first-line drug, and globally, just over half of patients with multi-drug resistant TB are successfully treated. More...08 Oct 2018
Nanopore Sequencing Enables Outbreak Field Surveillance
Outbreaks of fever of unknown origin start with nonspecific symptoms and case definition is only slowly developed and adapted, therefore, identifying the causative agent is crucial to ensure suitable treatment and control measures. More...03 Oct 2018
Disease Progression Apprised by Post-Treatment Mutation Sequencing
Allogeneic hematopoietic stem-cell transplantation is the only curative treatment for patients with myelodysplastic syndrome (MDS). The molecular predictors of disease progression after transplantation are unclear. More...26 Sep 2018
DNA Test Predicts Risk of Leukemia Relapse
Acute myeloid leukemia (AML) is the most common type of leukemia in adults, comprising about one quarter of all cases. The disease stems from an overproduction of immature blood cells in the bone marrow, which over time outgrow normal blood cells. It's a type of cancer, which starts suddenly and progresses quickly, requiring urgent treatment. More...25 Sep 2018
Gold Member
Automated MALDI-TOF MS System
EXS 3000
 assay.jpg)
New
Gold Member
Ketosis and DKA Test
D-3-Hydroxybutyrate (Ranbut) Assay
8-Channel Pipette
SAPPHIRE 20–300 µL
In Other News
MALDI-TOF MS Used to Identify Pythiosis
Determining Fibrosis Stage in Non-Alcoholic Fatty Liver Disease
Biomarkers Measured for Early Detection of Huntington's Disease
Targeted Sequencing Approach for Sarcoma Gene Fusions Validated
New mRNA Cancer Drivers Revealed in Chronic Lymphocytic Leukemia
Elevated Gene Expression Correlates with Prostate Cancer Severity
Breast and Ovarian Cancers Associated with Predisposition Genes
Unexplained Illness Puts Pathogen Discovery to Test
Blood Test Predicts Lymphoma Therapy Success
Analysis of Nasal Polyps Suggests Mechanisms of Inflammation
New Test Predicts Potential Success of BCG Immunotherapy for Bladder Cancer
Rapid Method Suggested for Diagnosis of DVT
Multi-Omics Approach Guides Relapsed Multiple Myeloma Treatment
Whole-Genome Sequencing Diagnoses Early Infantile Epileptic Encephalopathy
DNA Screening and Invasive Testing Show Similar Miscarriage Rates
Improved Myeloma Diagnosis Based on Blood Count Components
ELISA kit Offers Enhanced Diagnosis of Zika Virus Infection
Genotyping Assay Integrated into Glioma Treatment
Blood-Based Test Predicts Benefits of Lung Cancer Treatment
Genetic Mutation Identified in Childhood Brain Disorder
Biomarker-Based Blood Test Developed for Early Cancer Diagnosis
Genetic Testing for Hypercholesterolemia Improves Diagnosis
Epigenetic Diagnostic Tool Detects Diseases in Newborns
Genetic Testing channel of LabMedica brings the latest in molecular genetics, cytogenetics, and epigenetics, and methods from PCR to FISH, and more.
